G-Protein Coupled Receptor 55 (GPR55) Antibody (Biotin)
260€ (50 µl)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
G-Protein Coupled Receptor 55 (GPR55) Antibody (Biotin)
category
Primary Antibodies
provider
Abbexa
reference
abx343038
tested applications
ELISA
Description
G-Protein Coupled Receptor 55 (GPR55) Antibody (Biotin) is a Rabbit Polyclonal antibody conjugated to Biotin for the detection of Human GPR55.
Documents del producto
Instrucciones
Data sheet
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | G-Protein Coupled Receptor 55 (GPR55) |
| Host | Rabbit |
| Reactivity | Human |
| Recommended Dilution | Optimal dilutions/concentrations should be determined by the end user. |
| Clonality | Polyclonal |
| Conjugation | Biotin |
| Isotype | IgG |
| Purification | Purified by antigen affinity chromatography. |
| Size 1 | 50 µl |
| Size 2 | 100 µl |
| Size 3 | 200 µl |
| Size 4 | 1 ml |
| Form | Liquid |
| Tested Applications | ELISA |
| Buffer | 0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% glycerol. |
| Availability | Shipped within 5-10 working days. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| UniProt ID | Q9Y2T6 |
| Gene ID | 9290 |
| OMIM | 604107 |
| Alias | GPR55,LPIR1 |
| Background | Antibody anti-GPR55 |
| Status | RUO |
Descripción
GPR55 is an orphan G protein-coupled receptor that has been proposed as a novel cannabinoid receptor due to its activation by endocannabinoids, including lysophosphatidylinositol (LPI), and synthetic cannabinoids. GPR55 is widely expressed in the brain, bone, gastrointestinal tract, and immune system, where it regulates diverse physiological processes. In the central nervous system, GPR55 modulates synaptic transmission, neuronal excitability, and pain perception, playing roles in neuropathic pain and neuroinflammation. In bone metabolism, GPR55 promotes osteoclast activity and bone resorption, implicating it in diseases like osteoporosis. In cancer, GPR55 is overexpressed in tumors such as breast, prostate, and pancreatic cancers, where it enhances cell proliferation, survival, and metastasis via LPI-mediated signaling. GPR55 activation triggers pathways such as RhoA/ROCK, ERK1/2, and NF-κB, influencing cell migration and inflammation. Dysregulation of GPR55 is associated with metabolic, inflammatory, and neoplastic diseases. Targeting GPR55 offers therapeutic potential for treating pain, bone disorders, and cancer, making it a key receptor in cannabinoid and lipid signaling research.
Related Products
G-Protein Coupled Receptor 55 (GPR55) Antibody
G-Protein Coupled Receptor 55 (GPR55) Antibody is a Rabbit Polyclonal antibody for the detection of Human GPR55.
Ver ProductoG-Protein Coupled Receptor 55 (GPR55) Antibody (HRP)
G-Protein Coupled Receptor 55 (GPR55) Antibody (HRP) is a Rabbit Polyclonal antibody conjugated to HRP for the detection of Human GPR55.
Ver Producto
G-Protein Coupled Receptor 55 (GPR55) Antibody (FITC)
G-Protein Coupled Receptor 55 (GPR55) Antibody (FITC) is a Rabbit Polyclonal antibody conjugated to FITC for the detection of Human GPR55.
Ver Producto